aTyr Pharma Announces Appointment of Jeffery S. Hatfield to its Board of Directors

SAN DIEGO, April 3, 2017 -- (Healthcare Sales & Marketing Network) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the appo... Biopharmaceuticals, Personnel aTyr Pharma, Physiocrine, Resolaris, facioscapulohumeral muscular dystrophy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news